Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
RSP promises diversification away from mega-cap dominance, but the costs hiding beneath its expense ratio tell a story most investors never think to ask about before buying in.
In the most recent trading session, Clearway Energy (CWEN) closed at $33.19, indicating a -1.43% shift from the previous trading day.
The latest trading day saw SolarEdge Technologies (SEDG) settling at $52.13, representing a -5.53% change from its previous close.
Retirees chasing yield often hand a significant slice of their income straight to the IRS, but the account where you hold a fund can matter just as much as the fund itself.
Vertex Pharmaceuticals (VRTX) reached $480.25 at the closing of the latest trading day, reflecting a -1.06% change compared to its last close.
Axon Enterprise (AXON) closed at $547 in the latest trading session, marking a -3.32% move from the prior day.
In the latest trading session, Owens Corning (OC) closed at $141.11, marking a -1.56% move from the previous day.
There's more than a couple of catalysts behind this rare-earth stock's rise.
The market is focused on sluggish top-line growth, but a different number reveals how the company is quietly creating shareholder value.
Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its stock price has climbed to $353.68, representing a healthy 30.1% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Toast (TOST) has been one of the market's overlooked names this year. While AI stocks pulled in more investor money, Toast, the company behind the tablets at your local restaurant, drifted lower. TOST fell roughly 19% over the past six months, even as the S&P 500 gained 7.4%. Then Goldman ...
BGC has had an impressive run over the past six months as its shares have beaten the S&P 500 by 16.3%. The stock now trades at $10.79, marking a 24.7% gain. This performance may have investors wondering how to approach the situation.
If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.
Renewed tensions in the Strait of Hormuz are rattling markets again.
Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.
While everyone chased AI darlings, a quiet dividend ETF sat ignored for three years and just staged a comeback that has income investors asking whether the whole playbook needs to change.
Major digital assets were broadly weaker Monday, with Bitcoin (BTC-USD) down but holding above the $
United Rentals currently trades at $1,096 and has been a dream stock for shareholders. It’s returned 248% since July 2021, more than tripling the S&P 500’s 72.6% gain. The company has also beaten the index over the past six months as its stock price is up 16.6% thanks to its solid quarterly results.
The S&P 500 (^GSPC) is holding strong despite the recent sell-off in chip stocks. Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look.
Euronet Worldwide has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7% to $76.96 per share while the index has gained 8.4%.
IXUS offers broader global diversification with higher returns, while SCHE targets emerging markets at lower cost. Which aligns with your investment goals?
Brinker International has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11.4% to $185.23 per share while the index has gained 8.4%.
Credit Acceptance’s 35.6% return over the past six months has outpaced the S&P 500 by 27.3%, and its stock price has climbed to $625.97 per share. This performance may have investors wondering how to approach the situation.
Colgate-Palmolive trades at $92.24 and has moved in lockstep with the market. Its shares have returned 11.2% over the last six months while the S&P 500 has gained 8.4%.
Investor expectations are high heading into the earnings season, leaving lots of room for disappointment. Consensus estimates signal S&P 500 earnings to grow 22% from the year-ago period, that’s after more than 27% growth in the first quarter, Bank of America reported. “Expectations are elevated, but we see no signs of earnings momentum rolling over,” Bank of America strategists said, issuing an earnings forecast that sat above consensus estimates and lifting their full-year EPS outlook.